These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 7687756

  • 1. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein.
    Kupferminc MJ, Tamura RK, Wigton TR, Glassenberg R, Socol ML.
    Obstet Gynecol; 1993 Aug; 82(2):266-9. PubMed ID: 7687756
    [Abstract] [Full Text] [Related]

  • 2. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein.
    Zelop C, Nadel A, Frigoletto FD, Pauker S, MacMillan M, Benacerraf BR.
    Obstet Gynecol; 1992 Oct; 80(4):693-4. PubMed ID: 1383899
    [Abstract] [Full Text] [Related]

  • 3. Unexplained positive/elevated maternal serum alpha-fetoprotein associated with placenta increta. A case report.
    McCool RA, Bombard AT, Bartholomew DA, Calhoun BC.
    J Reprod Med; 1992 Sep; 37(9):826-8. PubMed ID: 1280687
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta.
    Cali G, Forlani F, Giambanco L, Amico ML, Vallone M, Puccio G, Alio L.
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():36-41. PubMed ID: 24965977
    [Abstract] [Full Text] [Related]

  • 5. Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta.
    Shrivastava V, Nageotte M, Major C, Haydon M, Wing D.
    Am J Obstet Gynecol; 2007 Oct; 197(4):402.e1-5. PubMed ID: 17904978
    [Abstract] [Full Text] [Related]

  • 6. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
    Anfuso S, Soncini E, Bonelli P, Piantelli G, Gramellini D.
    Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
    [Abstract] [Full Text] [Related]

  • 7. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
    Silver RM, Draper ML, Byrne JL, Ashwood EA, Lyon JL, Branch DW.
    Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
    [Abstract] [Full Text] [Related]

  • 8. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP, Sikkema-Raddatz B, Beekhuis JR, De Wolf BT, Mantingh A.
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [Abstract] [Full Text] [Related]

  • 9. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
    Matsuzaki S, Mandelbaum RS, Sangara RN, McCarthy LE, Vestal NL, Klar M, Matsushima K, Amaya R, Ouzounian JG, Matsuo K.
    Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
    [Abstract] [Full Text] [Related]

  • 10. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta.
    Bodner LJ, Nosher JL, Gribbin C, Siegel RL, Beale S, Scorza W.
    Cardiovasc Intervent Radiol; 2006 Nov; 29(3):354-61. PubMed ID: 16502171
    [Abstract] [Full Text] [Related]

  • 11. Surgical management of placenta accreta: a 10-year experience.
    Grace Tan SE, Jobling TW, Wallace EM, McNeilage LJ, Manolitsas T, Hodges RJ.
    Acta Obstet Gynecol Scand; 2013 Apr; 92(4):445-50. PubMed ID: 23311505
    [Abstract] [Full Text] [Related]

  • 12. The maternal outcome in placenta accreta: the significance of antenatal diagnosis and non-separation of placenta at delivery.
    Wong HS, Hutton J, Zuccollo J, Tait J, Pringle KC.
    N Z Med J; 2008 Jul 04; 121(1277):30-8. PubMed ID: 18677328
    [Abstract] [Full Text] [Related]

  • 13. Placenta percreta: report of a case.
    Coates VA, Fishman MS, McCall WG.
    CRNA; 1999 Nov 04; 10(4):165-9. PubMed ID: 10723294
    [Abstract] [Full Text] [Related]

  • 14. Is placenta accreta catching up with us?
    Armstrong CA, Harding S, Matthews T, Dickinson JE.
    Aust N Z J Obstet Gynaecol; 2004 Jun 04; 44(3):210-3. PubMed ID: 15191444
    [Abstract] [Full Text] [Related]

  • 15. Placenta accreta--summary of 10 years: a survey of 310 cases.
    Gielchinsky Y, Rojansky N, Fasouliotis SJ, Ezra Y.
    Placenta; 2002 Jun 04; 23(2-3):210-4. PubMed ID: 11945088
    [Abstract] [Full Text] [Related]

  • 16. Placenta accreta, increta, and percreta. A survey of 40 cases.
    Breen JL, Neubecker R, Gregori CA, Franklin JE.
    Obstet Gynecol; 1977 Jan 04; 49(1):43-7. PubMed ID: 299782
    [Abstract] [Full Text] [Related]

  • 17. Interpregnancy interval as a risk factor for placenta accreta.
    Wax JR, Seiler A, Horowitz S, Ingardia CJ.
    Conn Med; 2000 Nov 04; 64(11):659-61. PubMed ID: 11125633
    [Abstract] [Full Text] [Related]

  • 18. Temporary cross-clamping of the infrarenal abdominal aorta during cesarean hysterectomy to control operative blood loss in placenta previa increta/percreta.
    Chou MM, Ke YM, Wu HC, Tsai CP, Ho ES, Ismail H, Palacios Jaraquemada JM.
    Taiwan J Obstet Gynecol; 2010 Mar 04; 49(1):72-6. PubMed ID: 20466297
    [Abstract] [Full Text] [Related]

  • 19. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
    Maher JE, Davis RO, Goldenberg RL, Boots LR, DuBard MB.
    Obstet Gynecol; 1994 Jan 04; 83(1):138-41. PubMed ID: 7505911
    [Abstract] [Full Text] [Related]

  • 20. Emergency obstetric hysterectomy.
    Daskalakis G, Anastasakis E, Papantoniou N, Mesogitis S, Theodora M, Antsaklis A.
    Acta Obstet Gynecol Scand; 2007 Jan 04; 86(2):223-7. PubMed ID: 17364287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.